gi-hepatology
Mumtaz Score for 30-Day Readmission in Cirrhosis
Predicts 30-day hospital readmission in cirrhotic patients following discharge. Identifies high-risk patients who may benefit from closer follow-up.
References
- Mumtaz K et al. Risk stratification of readmission in patients hospitalized for cirrhosis. J Clin Gastroenterol. 2019;53(9):e385–e390.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
- Spironolactone (Ascites / Cirrhosis) · Aldosterone Antagonist / Potassium-Sparing Diuretic
- Furosemide (Ascites / Cirrhosis) · Loop Diuretic
- Methotrexate (Dermatology — Psoriasis) · Disease-Modifying Antirheumatic / Immunosuppressant
- Acetazolamide (Ménière's Disease) · Carbonic Anhydrase Inhibitor (Diuretic)
- Zinc acetate · Zinc salt (Wilson's disease)
- Sulfasalazine · Aminosalicylate / Disease-Modifying Antirheumatic Drug (DMARD)
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.